298 related articles for article (PubMed ID: 10099541)
1. High yield refolding and purification process for recombinant human interleukin-6 expressed in Escherichia coli.
Ejima D; Watanabe M; Sato Y; Date M; Yamada N; Takahara Y
Biotechnol Bioeng; 1999 Feb; 62(3):301-10. PubMed ID: 10099541
[TBL] [Abstract][Full Text] [Related]
2. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of human and mouse recombinant alpha-fetoproteins expressed in Escherichia coli.
Boismenu R; Semeniuk D; Murgita RA
Protein Expr Purif; 1997 Jun; 10(1):10-26. PubMed ID: 9179285
[TBL] [Abstract][Full Text] [Related]
4. Expression and preparation of recombinant hepcidin in Escherichia coli.
Zhang H; Yuan Q; Zhu Y; Ma R
Protein Expr Purif; 2005 Jun; 41(2):409-16. PubMed ID: 15866729
[TBL] [Abstract][Full Text] [Related]
5. Renaturation of Escherichia coli-derived recombinant human macrophage colony-stimulating factor.
Tran-Moseman A; Schauer N; De Bernardez Clark E
Protein Expr Purif; 1999 Jun; 16(1):181-9. PubMed ID: 10336876
[TBL] [Abstract][Full Text] [Related]
6. High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials.
Frankel AE; Ramage J; Latimer A; Feely T; Delatte S; Hall P; Tagge E; Kreitman R; Willingham M
Protein Expr Purif; 1999 Jun; 16(1):190-201. PubMed ID: 10336877
[TBL] [Abstract][Full Text] [Related]
7. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
Vallejo LF; Rinas U
Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
[TBL] [Abstract][Full Text] [Related]
8. Refolding and purification of yeast carboxypeptidase Y expressed as inclusion bodies in Escherichia coli.
Hahm MS; Chung BH
Protein Expr Purif; 2001 Jun; 22(1):101-7. PubMed ID: 11388806
[TBL] [Abstract][Full Text] [Related]
9. High-level expression and purification of recombinant huGM-CSF (9-127)/IL-6 (29-184) fusion protein in Escherichia coil.
Sun QM; Jiang HC; Xu WM; Liu X; Dai CB; Sun MS
Protein Expr Purif; 2005 Aug; 42(2):278-85. PubMed ID: 15935697
[TBL] [Abstract][Full Text] [Related]
10. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies.
Richter W; Hermsdorf T; Kronbach T; Dettmer D
Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709
[TBL] [Abstract][Full Text] [Related]
11. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli.
Cherish Babu PV; Srinivas VK; Krishna Mohan V; Krishna E
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):218-26. PubMed ID: 17981102
[TBL] [Abstract][Full Text] [Related]
12. On-column refolding and purification of recombinant human interleukin-1 receptor antagonist (rHuIL-1ra) expressed as inclusion body in Escherichia coli.
Tan H; Dan G; Gong H; Cao L
Biotechnol Lett; 2005 Aug; 27(16):1177-82. PubMed ID: 16158260
[TBL] [Abstract][Full Text] [Related]
13. New fusion protein systems designed to give soluble expression in Escherichia coli.
Davis GD; Elisee C; Newham DM; Harrison RG
Biotechnol Bioeng; 1999 Nov; 65(4):382-8. PubMed ID: 10506413
[TBL] [Abstract][Full Text] [Related]
14. Refolding, purification, and characterization of a loop deletion mutant of human Bcl-2 from bacterial inclusion bodies.
Anderson M; Blowers D; Hewitt N; Hedge P; Breeze A; Hampton I; Taylor I
Protein Expr Purif; 1999 Mar; 15(2):162-70. PubMed ID: 10049671
[TBL] [Abstract][Full Text] [Related]
15. Refolding and purification of unprocessed porcine myostatin expressed in Escherichia coli.
Jin HJ; Dunn MA; Borthakur D; Kim YS
Protein Expr Purif; 2004 May; 35(1):1-10. PubMed ID: 15039059
[TBL] [Abstract][Full Text] [Related]
16. Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis.
Afzal AJ; Lightfoot DA
Protein Expr Purif; 2007 Jun; 53(2):346-55. PubMed ID: 17287130
[TBL] [Abstract][Full Text] [Related]
17. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
[TBL] [Abstract][Full Text] [Related]
18. Comparison of four methods for the purification and refolding of human interleukin-2-mouse granulocyte/macrophage colony-stimulating factor fusion protein.
Wen Q; Ma L; Luo W; Zhou MQ; He D; Lin Y; Wu ZQ; He XW; Wang JF; Wang XN
Biotechnol Appl Biochem; 2008 May; 50(Pt 1):41-8. PubMed ID: 17708750
[TBL] [Abstract][Full Text] [Related]
19. Recombinant fusion proteins for the industrial production of disulfide bridge containing peptides: purification, oxidation without concatamer formation, and selective cleavage.
Döbeli H; Andres H; Breyer N; Draeger N; Sizmann D; Zuber MT; Weinert B; Wipf B
Protein Expr Purif; 1998 Apr; 12(3):404-14. PubMed ID: 9535709
[TBL] [Abstract][Full Text] [Related]
20. Purification and refolding of recombinant human interferon-gamma in urea-ammonium chloride solution.
Petrov S; Nacheva G; Ivanov I
Protein Expr Purif; 2010 Sep; 73(1):70-3. PubMed ID: 20363329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
